Drugmaker CEOs see sales online channels as a budding opportunity, while some biotech investors told BioPharma Dive to expect ...
Viking CEO Brian Lian said at the conference earlier this week that the strategic interest in weight-loss drug deals is ...
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the ...
Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has ...
After an agency review, the FDA asked drugmakers to remove warnings about a potential risk of suicidal thoughts from widely ...